drugset / Trial / NCT00048022

Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent Asthma

NCT00048022 ↗

Phase 2 Completed Hoffmann-La Roche
Treatment

Summary

The primary objective of the study is to evaluate the anti-inflammatory action and safety of Ro 27-2441 (study drug) in asthmatic patients currently taking inhaled corticosteroids. The research is being conducted at up to 40 clinical research sites in the US. Study participants will have a number of visits to a research site over a 4-month period.

Timeline

Start
2002-10-25
Primary completion
2004-02-02
Completion
2004-02-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ro 27-2441 Unknown — —

Indications